Although the manner in which DSCAM-AS1 functions in breast cancers remains unclear, the RNA-binding protein heterogeneous nuclear ribonucleoprotein L (hnRNPL) is required for DSCAM-AS1 activity in MCF7 and T47D cells [110]. Here, HNRNPL is linked to breast carcinoma.